Mitch Dowsett

Active 1975–2023

283
Papers
91,599
Citations
144
h-index
283
i10-index

Citations

Citations per year for Mitch Dowsett1896: 1 citations1974: 1 citations1978: 2 citations1979: 2 citations1980: 6 citations1982: 1 citations1983: 2 citations1984: 1 citations1985: 3 citations1986: 3 citations1987: 7 citations1988: 9 citations1989: 10 citations1990: 28 citations1991: 12 citations1992: 33 citations1993: 37 citations1994: 39 citations1995: 51 citations1996: 63 citations1997: 31 citations1998: 88 citations1999: 98 citations2000: 115 citations2001: 149 citations2002: 141 citations2003: 250 citations2004: 240 citations2005: 324 citations2006: 385 citations2007: 534 citations2008: 707 citations2009: 634 citations2010: 745 citations2011: 858 citations2012: 726 citations2013: 865 citations2014: 744 citations2015: 775 citations2016: 705 citations2017: 730 citations2018: 729 citations2019: 2,519 citations2020: 2,675 citations2021: 2,589 citations2022: 1,954 citations2023: 1,474 citations2024: 2,245 citations2025: 1,080 citations2026: 41 citations1897–1973: no citations, so these years are not shown1975–1977: no citations, so these years are not shown1981: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 7,146 citing papers, 25.1% of this breakdownChina: 2,537 citing papers, 8.9% of this breakdownUnited Kingdom: 2,445 citing papers, 8.6% of this breakdownItaly: 1,620 citing papers, 5.7% of this breakdownGermany: 1,299 citing papers, 4.6% of this breakdownCanada: 1,098 citing papers, 3.9% of this breakdownFrance: 1,029 citing papers, 3.6% of this breakdownSpain: 863 citing papers, 3% of this breakdownNetherlands: 812 citing papers, 2.8% of this breakdownAustralia: 781 citing papers, 2.7% of this breakdownSwitzerland: 681 citing papers, 2.4% of this breakdownJapan: 670 citing papers, 2.4% of this breakdown
0%25.1%Other 26.3%

Fields

  • Medicine49.3%
  • Biochemistry, Genetics and Molecular Biology42.1%
  • Computer Science2.5%
  • Engineering1.5%
  • Immunology and Microbiology1.1%
  • Pharmacology, Toxicology and Pharmaceutics0.7%
  • Other2.8%

Topics

  • Breast Cancer Treatment Studies8.4%
  • HER2/EGFR in Cancer Research6.3%
  • Estrogen and related hormone effects4.9%
  • Advanced Breast Cancer Therapies3.9%
  • Cancer Genomics and Diagnostics3.9%
  • Cancer Cells and Metastasis3.7%
  • Other68.9%

Coauthors

All papers

Open in search
  1. Patient-derived organoids model treatment response of metastatic gastrointestinal cancers

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mitch Dowsett, Johann S. de Bono, Paul Workman, Anguraj Sadanandam, Matteo Fassan, Owen J. Sansom, Suzanne A. Eccles, Naureen Starling, Chiara Braconi, Andrea Sottoriva, Simon P. Robinson, David Cunningham, Nicola Valeri - Science 2018 cited by 2,131

  2. Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2020 cited by 1,497

  3. 20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years

    Authors: , , , , , , , , , , - New England Journal of Medicine 2017 cited by 1,810

  4. Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: ASCO–College of American Pathologists Guideline Update

    Authors: , , , , , , , , - Journal of Clinical Oncology 2023 cited by 581

  5. Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update

    Authors: , , , , , , , , , , , , , , , , - Archives of Pathology & Laboratory Medicine 2018 cited by 2,454

  6. American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , James L. Wittliff, Antonio C. Wolff - Archives of Pathology & Laboratory Medicine 2010 cited by 4,267

  7. Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mitch Dowsett, Frances Duane, Vaughan Evans, Marianne Ewertz, Bernard Fisher, John Forbes, Leslie G. Ford, J.-C. Gazet, Richard D. Gelber, Lucy Gettins, Luca Gianni, Michael Gnant, Jon Godwin, Aron Goldhirsch, Pamela J. Goodwin, Richard Gray, Daniel F. Hayes, Catherine Hill, James N. Ingle, Reshma Jagsi, R. Jakesz, Sam James, Wolfgang Janni, Hui Liu, Zulian Liu, Caroline Lohrisch, Sibylle Loibl, Liz MacKinnon, Andreas Makris, Eleftherios P. Mamounas, Gurdeep Mannu, Miguel Martín, S. Mathoulin, L. Mauriac, Paul McGale, Theresa McHugh, Philip Morris, Hirofumi Mukai, Larry Norton, Yasuo Ohashi, Ivo A. Olivotto, Soon Young Paik, Hongchao Pan, Richárd Pető, Martine Piccart, Lori J. Pierce, Philip Poortmans, Trevor J. Powles, K.I. Pritchard, Joseph Ragaz, Vinod Raina, Peter M. Ravdin, Simon Read, Meredith M. Regan, J.F.R. Robertson, Emiel J. Rutgers, Suzy Scholl, Dennis J. Slamon, Lidija Sölkner, Joseph A. Sparano, Seth M. Steinberg, Rosemary Sutcliffe, Sandra M. Swain, Carolyn Taylor, Andrew Tutt, Pinuccia Valagussa, Cornelis J.�H. van de Velde, Jos A. van der Hage, Giuseppe Viale, Gϋnter von Minckwitz and 10 more - The Lancet Oncology 2017 cited by 1,133

  8. Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group

    Authors: , , , , , , , , , , , , , , , , , , , , , - JNCI Journal of the National Cancer Institute 2020 cited by 733

  9. Early Adaptation and Acquired Resistance to CDK4/6 Inhibition in Estrogen Receptor–Positive Breast Cancer

    Authors: , , , , , , , , , , , , , , , , , , , - Cancer Research 2016 cited by 779

  10. Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer

    Authors: , , , , , , , , , , , , , , - Science Translational Medicine 2015 cited by 1,132

  11. Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mirko Dolci, Richard D. Gelber - New England Journal of Medicine 2005 cited by 5,098

  12. Assessment of Molecular Relapse Detection in Early-Stage Breast Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , - JAMA Oncology 2019 cited by 428

  13. 11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial

    Authors: , , , , , , , , , , , , , , , , , - The Lancet 2017 cited by 1,041

  14. Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Simon Read, Ewan Straiton, Raimund Jakesz, Christian Fesl, Olivia Pagani, Richard Gelber, Michelino De Laurentiis, Sabino De Placido, Ciro Gallo, Kathy Albain, Stewart Anderson, Rodrigo Arriagada, John Bartlett, Elizabeth Bergsten-Nordström, Judith Bliss, Etienne Brain, Lisa Carey, Robert Coleman, Jack Cuzick, Nancy Davidson, Lucia Del Mastro, Angelo Di Leo, James Dignam, Mitch Dowsett, Bent Ejlertsen, Matthew Goetz, Pam Goodwin, Pat Halpin-Murphy, Dan Hayes, Catherine Hill, Reshma Jagsi, Wolfgang Janni, Sibylle Loibl, Eleftherios P Mamounas, Miguel Martín, Hirofumi Mukai, Valentina Nekljudova, Larry Norton, Yasuo Ohashi, Lori Pierce, Philip Poortmans, Kathleen I Pritchard, Vinod Raina, Daniel Rea, John Robertson, Emiel Rutgers, Tanja Spanic, Joseph Sparano, Guenther Steger, Gong Tang, Masakazu Toi, Andrew Tutt, Giuseppe Viale, Xiang Wang, Tim Whelan, Nicholas Wilcken, Norman Wolmark, David Cameron, Jonas Bergh, Sandra M Swain - The Lancet Oncology 2022 cited by 299

  15. openalex_id:w4226348827

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Simon Read, Ewan Straiton, R. Jakesz, Christian Fesl, Olivia Pagani, Richard D. Gelber, Michelino De Laurentiis, Sabino De Placido, Ciro Gallo, Kathy S. Albain, Stewart Anderson, R. Arriagada, John M.S. Bartlett, Elizabeth Bergsten-Nordström, Judith M. Bliss, Étienne Brain, Lisa A. Carey, Robert E. Coleman, Jack Cuzick, Nancy Davidson, Lucia Del Mastro, Angelo Di Leo, James Dignam, Mitch Dowsett, Bent Ejlertsen, Matthew Goetz, Pam Goodwin, Pat Halpin-murphy, Dan Hayes, Catherine Hill, Reshma Jagsi, Wolfgang Janni, Sibylle Loibl, Eleftherios P Mamounas, Miguel Martín, Hirofumi Mukai, Valentina Nekljudova, Larry Norton, Yasuo Ohashi, Lori Pierce, Philip Poortmans, Kathleen I Pritchard, Vinod Raina, Daniel Rea, John Robertson, Emiel Rutgers, Tanja Spanic, Joseph Sparano, Guenther Steger, Gong Tang, Masakazu Toi, Andrew Tutt, Giuseppe Viale, Xiang Wang, Tim Whelan, Nicholas Wilcken, Norman Wolmark, David Cameron, Jonas Bergh, Sandra M Swain cited by 223

  16. Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jon Godwin, Sam James, Hui Liu, Elizabeth MacKinnon, Gurdeep Mannu, Theresa McHugh, Philip Morris, Simon Read, Ewan Straiton, Yaochen Wang, John Crown, Evandro de Azambuja, Suzette Delaloge, Helena Fung, Charles E. Geyer, M. Spielmann, Pinuccia Valagussa, Kathy S. Albain, Stewart Anderson, R. Arriagada, John Bartlett, Elizabeth Bergsten-Nordström, Judith M. Bliss, Étienne Brain, Lisa Carey, Robert E. Coleman, Jack Cuzick, Nancy E. Davidson, Lucia Del Mastro, Angelo Di Leo, James J. Dignam, Mitch Dowsett, Bent Ejlertsen, Prue Francis, Michael Gnant, Matthew Bidwell Goetz, Pam Goodwin, Pat Halpin-Murphy, Daniel Hayes, Catherine Hill, Reshma Jagsi, Wolfgang Janni, Sibylle Loibl, Eleftherios P. Mamounas, Miguel Martín, Hirofumi Mukai, Valentina Nekljudova, Larry Norton, Yasuo Ohashi, Lori J. Pierce, Philip Poortmans, Vinod Raina, Daniel Rea, Meredith M. Regan, J.F.R. Robertson, Emiel J. Rutgers, Tanja Španić, Joseph A. Sparano, Guenther G. Steger, Gong Tang, Masakazu Toi, Andrew Tutt, Giuseppe Viale, Xiang Wang, Timothy J. Whelan, Nicholas Wilcken, Norman Wolmark, David Cameron, Jonas Bergh, Kathleen I. Pritchard and 1 more - The Lancet Oncology 2021 cited by 348

  17. Plasma ESR1 Mutations and the Treatment of Estrogen Receptor–Positive Advanced Breast Cancer

    Authors: , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2016 cited by 718

  18. Long-term outcome and prognostic value of Ki67 after perioperative endocrine therapy in postmenopausal women with hormone-sensitive early breast cancer (POETIC): an open-label, multicentre, parallel-group, randomised, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2020 cited by 317

  19. Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update

    Authors: , , , , , , , , , , , , , , , , , , , - Archives of Pathology & Laboratory Medicine 2013 cited by 4,061

  20. Estrogen and Progesterone Receptor Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Guideline Update

    Authors: , , , , , , , , , , , , , , , , , , , - Archives of Pathology & Laboratory Medicine 2020 cited by 369

  21. Analysis of ESR1 mutation in circulating tumor DNA demonstrates evolution during therapy for metastatic breast cancer

    Authors: , , , , , , , , , , , , , , , , - Science Translational Medicine 2015 cited by 564

  22. Radiotherapy to regional nodes in early breast cancer: an individual patient data meta-analysis of 14 324 women in 16 trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jon Godwin, Sam James, Amanda Kerr, Hui Liu, Elizabeth MacKinnon, Gurdeep Mannu, Theresa McHugh, Philip Morris, Mariko Nakahara, Simon Read, Hannah Taylor, John Ferguson, H Scheurlen, Stefano Zurrida, Viviana Galimberti, James N. Ingle, Pinuccia Valagussa, Umberto Veronesi, Stewart Anderson, Gong Tang, Bernard Fisher, Sophie D. Fosså, Kristin V. Reinertsen, Herman Høst, Hyman B. Muss, Kaija Holli, Kathy S. Albain, R. Arriagada, John M.S. Bartlett, Elizabeth Bergsten-Nordström, Judith M. Bliss, Étienne Brain, Lisa A. Carey, Robert E. Coleman, Jack Cuzick, Nancy E. Davidson, Lucia Del Mastro, Angelo Di Leo, James J. Dignam, Mitch Dowsett, Bent Ejlertsen, Prue Francis, José Á. García-Sáenz, Rich Gelber, Michael Gnant, Matthew P. Goetz, Pam Goodwin, Pat Halpin-Murphy, Dan Hayes, Catherine Hill, Reshma Jagsi, Wolfgang Janni, Sibylle Loibl, Eleftherios P. Mamounas, Miguel Martín, Stuart McIntosh, Hirofumi Mukai, Valentina Nekljudova, Larry Norton, Yasuo Ohashi, Martine Piccart, Lori J. Pierce, Vinod Raina, Daniel Rea, Meredith M. Regan, J.F.R. Robertson, Emiel J. Rutgers, Roberto Salgado, Dennis J. Slamon, Tanja Španić and 14 more - The Lancet 2023 cited by 151

  23. American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Archives of Pathology & Laboratory Medicine 2006 cited by 4,475

  24. American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer (Unabridged Version)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , James L. Wittliff, Antonio C. Wolff - Archives of Pathology & Laboratory Medicine 2010 cited by 1,048